You have no items in your shopping cart.
On Promotion
Species Host
Tested Applications
Reactivity
Predicted Reactivity
Conjugation
Unconjugated 2838FITC 484Biotin 480HRP 463PE 401APC 307Cy3 258AP 241PerCP 231PE/Cy5 203APC/Cy5.5 202BF405 202BF488 202PE/Cy5.5 202PE/Cy7 202PerCP/Cy5.5 202APC/Cy7 201BF350 201BF555 201BF680 201BF700 201BF750 201Cy5 201Cy5.5 201Pacific Blue 201PerCP/Cy7 201RBITC 201BF594 200BF647 200Cy7 199IRDye800 155AE 43Fluoro488 35Fluoro550 35Fluoro594 35Fluoro647 35RPE 14SureLight 488 6IRDye800CW 2MMAE 1
Biologically Active
Featured Product
Search results for: 'apoptosis'
RecombinantIL-3,Human [orb1494821]> 95% as analyzed by SDS-PAGE and HPLC.
15.2 kDa, observed by non-reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg- RecombinantIL-21,Mouse [orb1494824]
> 95% as analyzed by SDS-PAGE.
15.1 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg - RecombinantIL-21,Human [orb1494825]
> 95% by SDS-PAGE analysis.
15.4 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg - RecombinantIFN-γ,Rat [orb1494841]
> 95% as analyzed by SDS-PAGE and HPLC.
15.5 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
1 mg, 10 μg, 50 μg - RecombinantIFN-γ,Mouse [orb1494842]
> 95% as analyzed by reducing SDS-PAGE.
15 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
1 mg, 20 μg, 100 μg - RecombinantIFN-γ,Human [orb1494843]
> 95% as analyzed by reducing SDS‐PAGE.
17kDa, observed by reducing SDS‐PAGE.
Escherichia coli.
10 μg, 50 μg, 100 μg - RecombinantFGF-basic,Rat [orb1494863]
> 95% by SDS-PAGE analysis.
16.4 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg > 95% by SDS-PAGE analysis.
16.4 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg> 95% by SDS-PAGE analysis.
17.1 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg> 95% by SDS-PAGE analysis.
16.4 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg